Literature DB >> 24033869

Rates of new infections in British Columbia continue to decline at a faster rate than in other Canadian regions.

R S Hogg1, B Nosyk, P R Harrigan, V D Lima, K Chan, K Heath, E Wood, T Kerr, J S G Montaner.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24033869      PMCID： PMC4539005          DOI： 10.1111/hiv.12079

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  11 in total

1.  Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.

Authors:  Caroline E Sloan; Karen Champenois; Philippe Choisy; Elena Losina; Rochelle P Walensky; Bruce R Schackman; Faiza Ajana; Hugues Melliez; A D Paltiel; Kenneth A Freedberg; Yazdan Yazdanpanah
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

Review 2.  The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.

Authors:  Julio S G Montaner; Robert Hogg; Evan Wood; Thomas Kerr; Mark Tyndall; Adrian R Levy; P Richard Harrigan
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

3.  Treatment as prevention--a double hat-trick.

Authors:  Julio S G Montaner
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

4.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

5.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

6.  Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan.

Authors:  Chi-Tai Fang; Hsu-Mei Hsu; Shiing-Jer Twu; Mao-Yen Chen; Yu-Yin Chang; Jing-Shiang Hwang; Jung-Der Wang; Che-Yen Chuang
Journal:  J Infect Dis       Date:  2004-07-22       Impact factor: 5.226

Review 7.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.

Authors:  Suzanna Attia; Matthias Egger; Monika Müller; Marcel Zwahlen; Nicola Low
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

8.  Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.

Authors:  Travis C Porco; Jeffrey N Martin; Kimberly A Page-Shafer; Amber Cheng; Edwin Charlebois; Robert M Grant; Dennis H Osmond
Journal:  AIDS       Date:  2004-01-02       Impact factor: 4.177

9.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

Authors: 
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

10.  Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

Authors:  Evan Wood; Thomas Kerr; Brandon D L Marshall; Kathy Li; Ruth Zhang; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  BMJ       Date:  2009-04-30
View more
  8 in total

1.  Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.

Authors:  Bohdan Nosyk; Xiao Zang; Jeong E Min; Emanuel Krebs; Viviane D Lima; M-J Milloy; Jean Shoveller; Rolando Barrios; P Richard Harrigan; Thomas Kerr; Evan Wood; Julio S G Montaner
Journal:  Lancet HIV       Date:  2017-03-30       Impact factor: 12.767

2.  Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.

Authors:  Bohdan Nosyk; Jeong E Min; Viviane D Lima; Robert S Hogg; Julio S G Montaner
Journal:  Lancet HIV       Date:  2015-07-16       Impact factor: 12.767

Review 3.  The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.

Authors:  Katherine R Schafer; Helmut Albrecht; Rebecca Dillingham; Robert S Hogg; Denise Jaworsky; Ken Kasper; Mona Loutfy; Lauren J MacKenzie; Kathleen A McManus; Kris Ann K Oursler; Scott D Rhodes; Hasina Samji; Stuart Skinner; Christina J Sun; Sharon Weissman; Michael E Ohl
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

Review 4.  Treatment as prevention: toward an AIDS-free generation.

Authors:  Julio S G Montaner
Journal:  Top Antivir Med       Date:  2013 Jul-Aug

5.  Setting the stage for expanding HIV pre-exposure prophylaxis use in Canada.

Authors:  M Hull; Dhs Tan
Journal:  Can Commun Dis Rep       Date:  2017-12-07

6.  Phylogenetic prioritization of HIV-1 transmission clusters with viral lineage-level diversification rates.

Authors:  Rachel L Miller; Angela McLaughlin; Richard H Liang; John Harding; Jason Wong; Anh Q Le; Chanson J Brumme; Julio S G Montaner; Jeffrey B Joy
Journal:  Evol Med Public Health       Date:  2022-07-22

7.  Optimizing HIV pre-exposure prophylaxis implementation among men who have sex with men in a large urban centre: a dynamic modelling study.

Authors:  Derek R MacFadden; Darrell H Tan; Sharmistha Mishra
Journal:  J Int AIDS Soc       Date:  2016-09-23       Impact factor: 5.396

8.  Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men.

Authors:  Adrien Le Guillou; Susan Buchbinder; Hyman Scott; Albert Liu; Diane Havlir; Susan Scheer; Samuel M Jenness
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-01       Impact factor: 3.771
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.